Ilex Medical Stock Current Asset
| ILX Stock | 6,870 15.00 0.22% |
Ilex Medical fundamentals help investors to digest information that contributes to Ilex Medical's financial success or failures. It also enables traders to predict the movement of Ilex Stock. The fundamental analysis module provides a way to measure Ilex Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ilex Medical stock.
Ilex |
Ilex Medical Company Current Asset Analysis
Ilex Medical's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
In accordance with the recently published financial statements, Ilex Medical has a Current Asset of 0.0. This indicator is about the same for the Health Care Providers & Services average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Israel stocks average (which is currently at 0.0).
Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
| All Next | Launch Module |
Ilex Fundamentals
| Return On Equity | 0.19 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 901.49 M | |||
| Shares Outstanding | 11.19 M | |||
| Shares Owned By Insiders | 62.44 % | |||
| Shares Owned By Institutions | 10.16 % | |||
| Price To Book | 1.83 X | |||
| Price To Sales | 1.16 X | |||
| Revenue | 1.06 B | |||
| Gross Profit | 379.38 M | |||
| EBITDA | 307.85 M | |||
| Net Income | 197.48 M | |||
| Cash And Equivalents | 118.65 M | |||
| Cash Per Share | 11.80 X | |||
| Total Debt | 1.28 M | |||
| Debt To Equity | 38.00 % | |||
| Current Ratio | 1.75 X | |||
| Book Value Per Share | 51.14 X | |||
| Cash Flow From Operations | 270.68 M | |||
| Earnings Per Share | 9.75 X | |||
| Number Of Employees | 254 | |||
| Beta | -0.11 | |||
| Market Capitalization | 1.01 B | |||
| Total Asset | 875.07 M | |||
| Annual Yield | 0.06 % | |||
| Five Year Return | 2.47 % | |||
| Net Asset | 875.07 M | |||
| Last Dividend Paid | 5.32 |
About Ilex Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ilex Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ilex Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ilex Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ilex Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Ilex Stock analysis
When running Ilex Medical's price analysis, check to measure Ilex Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ilex Medical is operating at the current time. Most of Ilex Medical's value examination focuses on studying past and present price action to predict the probability of Ilex Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ilex Medical's price. Additionally, you may evaluate how the addition of Ilex Medical to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |